Predictions
Formycon AG
Start price
Target price
Perf. (%)
€65.20
12.12.20
12.12.20
-
12.12.21
12.12.21
-7.06%
11.03.21
11.03.21
Could be worthwhile Investment >10% per year
Nanorepro AG
Start price
Target price
Perf. (%)
€3.38
26.11.20
26.11.20
-
16.11.21
16.11.21
198.22%
17.11.21
17.11.21
Could be worthwhile Investment >10% per year
Standard Investments for future growth
Revenue growth >5% per year expected
Lower EBIT Margin than peer group
MagForce AG
Start price
Target price
Perf. (%)
€3.01
18.11.20
18.11.20
€4.00
18.11.21
18.11.21
12.29%
19.11.21
19.11.21
Could be worthwhile Investment >10% per year
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€36.97
12.11.20
12.11.20
€50.00
12.11.21
12.11.21
21.49%
13.07.21
13.07.21
Top 10 in its market
Small cyclical dependencies
Below average Management
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€34.41
09.11.20
09.11.20
€40.00
09.11.21
09.11.21
18.27%
02.11.21
02.11.21
Could be very worthwhile Investment >20% year
Market Leader or Top 3
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Bio-Gate AG
Start price
Target price
Perf. (%)
€5.90
04.11.20
04.11.20
-
04.11.21
04.11.21
-32.20%
05.11.21
05.11.21
Growths faster than the competition
Few uniques
Dependend from some customers or products
Probably not worthwhile Investment
Epigenomics AG NA
Start price
Target price
Perf. (%)
€0.51
18.10.20
18.10.20
€1.00
02.11.20
02.11.20
20.00%
02.11.20
02.11.20
Could be worthwhile Investment >10% per year
Capable Management
Very good company culture
Innovative
Medigene AG
Start price
Target price
Perf. (%)
€3.51
15.10.20
15.10.20
€5.00
19.10.20
19.10.20
0.28%
19.10.20
19.10.20
Could be worthwhile Investment >10% per year
Merck KGaA
Start price
Target price
Perf. (%)
€124.80
23.09.20
23.09.20
-
04.11.21
04.11.21
4.17%
25.11.20
25.11.20
ROE higher than 10% per year
Low dividend yield expected
Medigene AG
Start price
Target price
Perf. (%)
€4.63
16.09.20
16.09.20
€6.00
21.09.20
21.09.20
-4.54%
21.09.20
21.09.20
Could be worthwhile Investment >10% per year
Stratec SE
Start price
Target price
Perf. (%)
€103.60
29.08.20
29.08.20
€120.00
31.08.20
31.08.20
-3.09%
31.08.20
31.08.20
Risky Investment
Stratec SE
Start price
Target price
Perf. (%)
€105.60
28.08.20
28.08.20
€95.00
04.11.21
04.11.21
5.30%
17.06.21
17.06.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
High valuation
Very low/no dividend yield expected
CytoTools AG
Start price
Target price
Perf. (%)
€10.20
12.08.20
12.08.20
€26.00
04.11.21
04.11.21
56.86%
13.04.21
13.04.21
Could be very worthwhile Investment >20% year
Differentiated customer and product portfolio